The DOI matches its Crossref record.
Diagnostic efficiency, embryonic development and clinical outcome after the biopsy of one or two blastomeres for preimplantation genetic diagnosis
Open accessAbstract
BACKGROUND: Preimplantation genetic diagnosis or screening (PGD, PGS) involves embryo biopsy on Day 3. Opting for one- or two-cell biopsy is a balance between the lowest risk for misdiagnosis on the one hand and the highest chance for a pregnancy on the other hand. METHODS: A prospective controlled trial was designed and 592 ICSI cycles were randomly assigned to the one-cell (group I) or the two-cell group (group II). Primary outcomes were diagnostic efficiency and embryonic development to delivery with live birth (analysed by cycle). The false-positive rate for the PCR cycles is presented as a secondary outcome (analysed by embryo). RESULTS: A strong significant correlation was observed between embryonic developmental stage on Day 3 and post-biopsy in vitro development on Day 5 (P < 0.0001). The influence of the intervention on Day 3 was less significant (P = 0.007): the biopsy of one cell is less invasive than the biopsy of two cells. PCR diagnostic efficiency was 88.6% in group I and 96.4% in group II (P = 0.008). For the fluorescence in situ hybridization (FISH) PGD cycles no significant difference in efficiency was obtained (98.2 and 97.5% in group I and II, respectively). Similar delivery rates with live birth per started cycle were obtained [58/287 or 20.2% in group I versus 52/303 or 17.2% in group II, P = 0.358; the absolute risk reduction = 3.05%; 95% confidence interval (CI): -3.24, 9.34]. Post-PGD PCR reanalysis showed six false positives in 97 embryos (6.2%) in group II and none in group I (91 embryos reanalysed). No false negatives were found. CONCLUSIONS: While removal of two blastomeres decreases the likelihood of blastocyst formation, compared with removal of one blastomere, Day 3 in vitro developmental stage is a stronger predictor for Day 5 developmental potential than the removal of one or two cells. The biopsy of only one cell significantly lowers the efficiency of a PCR-based diagnosis, whereas the efficiency of the FISH PGD procedure remains similar whether one or two cells are removed. Delivery rates with live birth per started cycle were not significantly different.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Recurrent implantation failure: definition and management
Coughlan, C., Ledger, W., Wang, Q., Liu, F., Demirol, A., Gurgan, T., Cutting, R., Ong, K., Sallam, H., & Li, T. C. (2014) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2013.08.011 · Cited by 904
Preimplantation genetic screening: a systematic review and meta-analysis of RCTs
Mastenbroek, S., Twisk, M., van der Veen, F., & Repping, S. (2011) · Human Reproduction Update · doi:10.1093/humupd/dmr003 · Cited by 433
The causes of misdiagnosis and adverse outcomes in PGD
Wilton, L., Thornhill, A., Traeger-Synodinos, J., Sermon, K. D., & Harper, J. C. (2009) · Human Reproduction · doi:10.1093/humrep/den488 · Cited by 300
Self-citationPGD for reciprocal and Robertsonian translocations using array comparative genomic hybridization
Fiorentino, F., Spizzichino, L., Bono, S., Biricik, A., Kokkali, G., Rienzi, L., Ubaldi, F. M., Iammarrone, E., Gordon, A., & Pantos, K. (2011) · Human Reproduction · doi:10.1093/humrep/der082 · Cited by 277
Preimplantation genetic diagnosis at 20 years
Simpson, J. L. (2010) · Prenatal Diagnosis · doi:10.1002/pd.2552 · Cited by 117
“Considering existing RCTs, the ESHRE PGD Consortium generated a position statement recommending that PGD aneuploidy testing (termed PGS) should interrogate embryonic cells other than blastomeres and use methods other than FISH (Harper et al., 2010).”
BackgroundMethodInfluentialPREIMPLANTATION GENETIC TESTING: clinical experience of preimplantation genetic testing
De Rycke, M., Berckmoes, V., De Vos, A., Van De Voorde, S., Verdyck, P., Verpoest, W., & Keymolen, K. (2020) · Reproduction · doi:10.1530/rep-20-0082 · Cited by 34
Metadata
- Authors
- Goossens, V., De Rycke, M., De Vos, A., Staessen, C., Michiels, A., Verpoest, W., Van Steirteghem, A., Bertrand, C., Liebaers, I., Devroey, P., & Sermon, K.
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-03-01
- Volume
- 23
- Issue
- 3
- Pages
- 481-492
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- OpenAlex
- W2162466412
- Cited by
- 194
- References
- 0
- FWCI
- 20.47
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.